These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7906496)

  • 21. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443.
    Allison AC; Almquist SJ; Muller CD; Eugui EM
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):10-4. PubMed ID: 2063415
    [No Abstract]   [Full Text] [Related]  

  • 22. Mycophenolate mofetil for transplantation: new drug, old problems?
    Gray DW
    Lancet; 1995 Aug; 346(8972):390. PubMed ID: 7623565
    [No Abstract]   [Full Text] [Related]  

  • 23. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.
    Sun Y; Chung DH; Chu YK; Jonsson CB; Parker WB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):84-8. PubMed ID: 17060520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen.
    Ohata K; Espinoza JL; Lu X; Kondo Y; Nakao S
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):205-13. PubMed ID: 20736080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
    Klupp J; van Gelder T; Dambrin C; Regieli JJ; Boeke K; Billingham ME; Morris RE
    J Heart Lung Transplant; 2004 Mar; 23(3):334-51. PubMed ID: 15019644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis.
    Catapano CV; Dayton JS; Mitchell BS; Fernandes DJ
    Mol Pharmacol; 1995 May; 47(5):948-55. PubMed ID: 7746281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.
    Hackl A; Ehren R; Weber LT
    Pediatr Nephrol; 2017 Aug; 32(8):1315-1322. PubMed ID: 27312386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate mofetil for the induction and maintenance treatment of lupus nephritis.
    González-Rivera TC; McCune J
    Immunotherapy; 2011 Dec; 3(12):1431-40. PubMed ID: 22091679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
    Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G
    Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation.
    Allison AC; Eugui EM
    Transplant Proc; 1994 Dec; 26(6):3205-10. PubMed ID: 7998117
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of mycophenolate mofetil in heart transplantation.
    Mathieu P; Carrier M; White M; Pellerin M; Perrault L; Pelletier G; Robitaille D; Pelletier LC
    Can J Surg; 2000 Jun; 43(3):202-6. PubMed ID: 10851414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycophenolate mofetil monotherapy in liver transplantation.
    Stewart SF; Hudson M; Talbot D; Manas D; Day CP
    Lancet; 2001 Feb; 357(9256):609-10. PubMed ID: 11558493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GTP concentrations are elevated in erythrocytes of renal transplant recipients when conventional immunosuppression is replaced by the inosine monophosphate dehydrogenase inhibitor mycophenolic acid mofetil (MMF).
    Goldsmith DJ; Carrey EA; Edbury SM; Marinaki AM; Simmonds HA
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1407-9. PubMed ID: 15571268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IMP dehydrogenase inhibitors as immunomodulators.
    Mitchell BS; Dayton JS; Turka LA; Thompson CB
    Ann N Y Acad Sci; 1993 Jun; 685():217-24. PubMed ID: 8103312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of primary systemic vasculitis with the inosine monophosphate dehydrogenase inhibitor mycophenolic acid.
    Hiemstra TF; Jones RB; Jayne DR
    Nephron Clin Pract; 2010; 116(1):c1-10. PubMed ID: 20484933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDH.
    Watkins WJ; Chen JM; Cho A; Chong L; Collins N; Fardis M; Huang W; Hung M; Kirschberg T; Lee WA; Liu X; Thomas W; Xu J; Zeynalzadegan A; Zhang J
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3479-83. PubMed ID: 16621550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
    Leyssen P; Balzarini J; De Clercq E; Neyts J
    J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
    Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
    J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolic Acid and Its Derivatives as Potential Chemotherapeutic Agents Targeting Inosine Monophosphate Dehydrogenase in Trypanosoma congolense.
    Suganuma K; Sarwono AE; Mitsuhashi S; Jąkalski M; Okada T; Nthatisi M; Yamagishi J; Ubukata M; Inoue N
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4391-3. PubMed ID: 27139487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.